Reference
- Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674–8.
- Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149–53.
- Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982;11:81–6.
- Mutru O, Laakso M, Isomäki H, Koota K. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J 1985;290:1797–9.
- Laakso M, Mutru 0, Isomäki H, Koota K. Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis 1986;45:663–7.
- Symmons DPM, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well. J Rheumatol 1998;25:1072–7.
- Tiitinen S, Kaarela K, HelM H, Kautiainen H, Isomäki H. Amyloidosis - Incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993;22:158–61.
- Finnish Register for Kidney Diseases, Annual report 1997. The Finnish Association for Organ-transplant and Kidney Patients.
- Laiho K, Tiitinen S, Kaarela K, HelM H, Isomäki H. Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland. Clin Rheumatol 1999;18:122–3.
- Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 1987;6:27–38.
- David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993;11: 85–90.
- Ylinen K, Grönhagen-Riska C, Honkanen E, Ekstrand A, Metsdrinne K, Kuhlbäck B. Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 1992;7:908–12.
- Möttonen T, Hannonen P, Leirisalo-Repo M, Nissild M, Kautiainen H, Korpela M, et alfor the FIN-RACo trial group. Comparison of combination therapy with single drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353:1568–73.
- Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10–21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 1993;20: 2051–7.
- Myllykangas-Luosujärvi R, Aho K, Isomäki H. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol 1995;22: 2214–7.